Kymera Therapeutics, Inc.
IRAK4 DEGRADERS AND USES THEREOF
Last updated:
Abstract:
The present invention provides IRAK4 degraders, formulations and unit dosage forms thereof, and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2022
Issue date:
1 Sep 2022